Manish Kumar Tripathi

667 total citations
21 papers, 492 citations indexed

About

Manish Kumar Tripathi is a scholar working on Molecular Biology, Epidemiology and Neurology. According to data from OpenAlex, Manish Kumar Tripathi has authored 21 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Epidemiology and 5 papers in Neurology. Recurrent topics in Manish Kumar Tripathi's work include Autophagy in Disease and Therapy (5 papers), Parkinson's Disease Mechanisms and Treatments (4 papers) and Genetics and Neurodevelopmental Disorders (4 papers). Manish Kumar Tripathi is often cited by papers focused on Autophagy in Disease and Therapy (5 papers), Parkinson's Disease Mechanisms and Treatments (4 papers) and Genetics and Neurodevelopmental Disorders (4 papers). Manish Kumar Tripathi collaborates with scholars based in Israel, India and United States. Manish Kumar Tripathi's co-authors include Haitham Amal, Maryam Kartawy, Poonam Kakkar, Brijesh Kumar Singh, Mahendra Pratap Singh, Shashank Kumar Ojha, Igor Khaliulin, Saurabh Shukla, Devendra Kumar Patel and Anubhuti Dixit and has published in prestigious journals such as Scientific Reports, Free Radical Biology and Medicine and Journal of the American Society of Nephrology.

In The Last Decade

Manish Kumar Tripathi

20 papers receiving 487 citations

Peers

Manish Kumar Tripathi
Manish Kumar Tripathi
Citations per year, relative to Manish Kumar Tripathi Manish Kumar Tripathi (= 1×) peers Hirotaka Sekiguchi

Countries citing papers authored by Manish Kumar Tripathi

Since Specialization
Citations

This map shows the geographic impact of Manish Kumar Tripathi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manish Kumar Tripathi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manish Kumar Tripathi more than expected).

Fields of papers citing papers by Manish Kumar Tripathi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manish Kumar Tripathi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manish Kumar Tripathi. The network helps show where Manish Kumar Tripathi may publish in the future.

Co-authorship network of co-authors of Manish Kumar Tripathi

This figure shows the co-authorship network connecting the top 25 collaborators of Manish Kumar Tripathi. A scholar is included among the top collaborators of Manish Kumar Tripathi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manish Kumar Tripathi. Manish Kumar Tripathi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tripathi, Manish Kumar, et al.. (2025). Blocking nitric oxide production for glioblastoma: A targeted therapeutic approach. 1(3). 41–49.
2.
Permyakova, Anna, Liad Hinden, Saja Baraghithy, et al.. (2024). Renal Mitochondrial ATP Transporter Ablation Ameliorates Obesity-Induced CKD. Journal of the American Society of Nephrology. 35(3). 281–298. 9 indexed citations
3.
Tripathi, Manish Kumar, et al.. (2024). Neurons Specialize in Presynaptic Autophagy: A Perspective to Ameliorate Neurodegeneration. Molecular Neurobiology. 62(2). 2626–2640. 2 indexed citations
4.
Tripathi, Manish Kumar, et al.. (2024). Mutations associated with autism lead to similar synaptic and behavioral alterations in both sexes of male and female mouse brain. Scientific Reports. 14(1). 10–10. 16 indexed citations
5.
Ojha, Shashank Kumar, Awanish Kumar, Manish Kumar Tripathi, et al.. (2023). Effects of extended-release 7-nitroindazole gel formulation treatment on the behavior of Shank3 mouse model of autism. Nitric Oxide. 140-141. 41–49. 13 indexed citations
6.
Ojha, Shashank Kumar, et al.. (2023). Nitric Oxide Synthase Inhibition Prevents Cell Proliferation in Glioblastoma. Journal of Molecular Neuroscience. 73(11-12). 875–883. 15 indexed citations
7.
Tripathi, Manish Kumar, Shashank Kumar Ojha, Maryam Kartawy, et al.. (2023). The NO Answer for Autism Spectrum Disorder. Advanced Science. 10(22). e2205783–e2205783. 27 indexed citations
8.
Ojha, Sanjay Kumar, Manish Kumar Tripathi, Waseem Hamoudi, Igor Khaliulin, & Haitham Amal. (2023). P10.09.A TARGETING NITROSATIVE STRESS TO PREVENT NEUROBLASTOMA MALIGNANCY: INSIGHTS INTO THE MTOR SIGNALING PATHWAY. Neuro-Oncology. 25(Supplement_2). ii63–ii64. 1 indexed citations
9.
Tripathi, Manish Kumar, Shreesh Ojha, & Haitham Amal. (2023). 532P Nitric oxide is a target by a combo-drug for glioblastoma treatment. Annals of Oncology. 34. S403–S403. 1 indexed citations
10.
Tripathi, Manish Kumar, et al.. (2022). A cross-talk between nitric oxide and the glutamatergic system in a Shank3 mouse model of autism. Free Radical Biology and Medicine. 188. 83–91. 19 indexed citations
11.
Tripathi, Manish Kumar, et al.. (2022). Arsenic alters nitric oxide signaling similar to autism spectrum disorder and Alzheimer’s disease-associated mutations. Translational Psychiatry. 12(1). 127–127. 32 indexed citations
12.
Kartawy, Maryam, et al.. (2021). Proteomics of autism and Alzheimer’s mouse models reveal common alterations in mTOR signaling pathway. Translational Psychiatry. 11(1). 480–480. 37 indexed citations
13.
Tripathi, Manish Kumar, Maryam Kartawy, & Haitham Amal. (2020). The role of nitric oxide in brain disorders: Autism spectrum disorder and other psychiatric, neurological, and neurodegenerative disorders. Redox Biology. 34. 101567–101567. 120 indexed citations
14.
Tripathi, Manish Kumar, et al.. (2019). Silymarin Protects Against Impaired Autophagy Associated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinsonism. Journal of Molecular Neuroscience. 70(2). 276–283. 19 indexed citations
15.
Tripathi, Manish Kumar, et al.. (2018). Malfunctioning of Chaperone-Mediated Autophagy in Parkinson’s Disease: Feats, Constraints, and Flaws of Modulators. Neurotoxicity Research. 35(1). 260–270. 16 indexed citations
16.
Tripathi, Manish Kumar, et al.. (2015). Resveratrol Protects from Toxin-Induced Parkinsonism: Plethora of Proofs Hitherto Petty Translational Value. Molecular Neurobiology. 53(5). 2751–2760. 35 indexed citations
17.
Shukla, Saurabh, et al.. (2014). Aberrant Autophagy and Parkinsonism: Does Correction Rescue from Disease Progression?. Molecular Neurobiology. 51(3). 893–908. 24 indexed citations
18.
Tripathi, Manish Kumar, Brijesh Kumar Singh, & Poonam Kakkar. (2008). Glycyrrhizic acid modulates t-BHP induced apoptosis in primary rat hepatocytes. Food and Chemical Toxicology. 47(2). 339–347. 68 indexed citations
19.
Tripathi, Manish Kumar, Uma Roy, Umesh K. Jinwal, Swatantra Kumar Jain, & Prasun Kumar Roy. (2004). Cloning, sequencing and structural features of a novel Streptococcus lipase. Enzyme and Microbial Technology. 34(5). 437–445. 16 indexed citations
20.
Tripathi, Manish Kumar, et al.. (1999). Chemoselective Hydrolysis of Esters by Fungal Lipase. Journal of Chemical Research Synopses. 266–267. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026